TY - JOUR AU - Law, Jia Hao AU - Xiang Koh, Frederick Hong AU - Wang, Shi AU - Tan, Ker Kan PY - 2018 TI - Curative treatment for metastatic colorectal cancer in the young population: is it worth it? JF - Journal of Gastrointestinal Oncology; Vol 10, No 1 (February 01, 2019): Journal of Gastrointestinal Oncology Y2 - 2018 KW - N2 - Background: A significant proportion of patients with colorectal cancer (CRC) presents with metastatic disease. In younger patients, a more aggressive approach is often adopted in an attempt to achieve cure and improve survival. The aim of this paper is to review the management and outcomes of young patients with metastatic CRC. Methods: All patients under 50 years diagnosed with CRC in a single institution from January 2007 to December 2015 were reviewed. Patient demographics, details of their treatments, progress and outcomes of treatment were collected for our review. Results: There were 154 newly diagnosed CRC patients who were vs . 24 months, P=0.140). Conclusions: Young CRC patients with stage IV disease typically survive for 2 years upon diagnosis. Those who were treated and underwent surgery with curative intent have a slightly longer but not statistically significant median survival than those treated with palliative intent. The role of aggressive treatment in these young patients with metastatic patients merits further evaluation. UR - https://jgo.amegroups.org/article/view/24542